Christopher Flint OBrien, Former Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 6,240 shares at $83.01 ($518K) on 2018-02-05, disclosed to the SEC on 2018-02-07.
Open-market sale of $518k NBIX by Former Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $83.01 | 1,500 | $125K | 24.0% |
| 2 | $83.01 | 1,500 | $125K | 24.0% |
| 3 | $83.40 | 1,113 | $93K | 17.9% |
| 4 | $83.40 | 1,113 | $93K | 17.9% |
| 5 | $82.48 | 1,014 | $84K | 16.1% |
| Total | $83.06 avg | 6,240 |
| $518K |
| 100% |
| Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |
| NBIX | SELL | 2017-07-31 | $437K | — | Filing → |